As the world population ages, an expected increase in the prevalence of chronic kidney
disease (CKD) among older individuals will pose a considerable challenge for health care …

With the growing number of dialysis patients with frailty, the concept of renal rehabilitation,
including exercise intervention and nutrition programs for patients with chronic kidney …

Background Current anemia therapies for patients with non–dialysis-dependent CKD may
require injection and medical visits. Roxadustat, an oral hypoxia-inducible factor prolyl …

Objective: to verify the association between the health-related quality of life of chronic renal
patients on hemodialysis with sociodemographic, clinical, depression and medication …

Introduction: In the last three decades, health systems have continued to pay increasing
attention to the quality of life (QOL) due to definitional changes in the concept of health and …

Rationale & Objective Anemia is common in chronic kidney disease (CKD); although
anemia is associated with adverse outcomes, the available treatments are not ideal. We …

Background: Anemia is a common complication of chronic kidney disease. The hypoxia-
inducible factor prolyl hydroxylase inhibitor (HIF-PHI) is a new class of oral drugs for the …

Objetivo: verificar la asociación entre la calidad de vida relacionada con la salud de los
pacientes renales crónicos sometidos a hemodiálisis con las características …

Elevations in plasma phosphate concentrations (hyperphosphatemia) occur in chronic
kidney disease (CKD), in certain genetic disorders, and following the intake of a phosphate …

Anemia is a common complication of chronic kidney disease (CKD) and is associated with
increased mortality and reduced health-related quality of life. Anemia is characterized by a …